I

INBX

INBX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
INBX Live QuoteReal-time
$74.33
$23.86(-24.30%)1M
Day Range$69.48 – $80.74
Open$70.19
Previous Close$69.06
Volume420.9K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.10B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-9.06
Price to Book7.4
Dividend Yield0.65%
Beta (Volatility)4.04
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $74.33 (17%)
Low: $57.30High: $155.29
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$258.33+72.2% upside

Insider Buys

3

$9.71M

Insider Sales

0

$0

Total Volume

$9.71M

3 transactions

Net Activity

+$9.71M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

2 Insiders

2 buys0 sells

$8.71M total

L
2

Lappe Mark

CEO

1 buys0 sells

$999K total

Trading History
INBX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 14, 2026

1 months ago

Multiple Insiders

2 Insiders

Insider
Buy47.5K$100.54$4.78M

Sep 25, 2026

1 months ago

Multiple Insiders

2 Insiders

Insider
Buy37.5K$104.82$3.93M

Sep 25, 2026

1 months ago

Lappe Mark

CEO

CEO
Buy10.0K$99.88$999K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
INBX Buy Conviction100%
Industry Rank#0 of 570
Volume Contribution0.1%
Total Industry Activity$16.52B

INBX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for INBX

Over the last 90 days, corporate insiders at INBX (INBX) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $9.71M.

The net insider activity for INBX shows a net buying bias of $9.71M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Multiple Insiders (2 Insiders), who traded 47.5K shares valued at $4.78M on Oct 14, 2026.

Live Market News & Developments
Aggregated real-time headlines for INBX (INBX)
6 updates

Inhibrx Biosciences, Inc. (INBX) stock price, news, quote and history

Yahoo Finance Singapore2d ago

Inhibrx Stock Price Forecast. Should You Buy INBX?

StockInvest.us2d ago

INBX - Inhibrx Biosciences Inc Stock Price and Quote

Finviz176d ago

Why Inhibrx Biosciences (INBX) Stock Is Down Today

Quiver Quantitative73d ago

Inhibrx Biosciences (INBX) Jumped, So What Is Behind The Move?

Yahoo Finance10h ago

Should I buy Inhibrx Biosciences, Inc. (INBX)

Zacks Investment Research211d ago

FAQs About INBX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for INBX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for INBX is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 3 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for INBX is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.